Consolidated Balance Sheet

KYORIN Pharmaceutical Co., Ltd. - Filing #7351594

Concept As at
2023-12-31
As at
2023-03-31
Consolidated balance sheet
Balance sheet
Assets
Current assets
Cash and deposits
19,149,000,000 JPY
19,394,000,000 JPY
Merchandise and finished goods
19,619,000,000 JPY
19,074,000,000 JPY
Work in process
14,791,000,000 JPY
9,079,000,000 JPY
Raw materials and supplies
19,385,000,000 JPY
19,872,000,000 JPY
Other
3,578,000,000 JPY
4,349,000,000 JPY
Allowance for doubtful accounts
-39,000,000 JPY
-41,000,000 JPY
Current assets
120,501,000,000 JPY
119,030,000,000 JPY
Non-current assets
58,440,000,000 JPY
57,014,000,000 JPY
Investments and other assets
24,542,000,000 JPY
25,785,000,000 JPY
Investment securities
21,302,000,000 JPY
22,979,000,000 JPY
Deferred tax assets
1,439,000,000 JPY
1,316,000,000 JPY
Allowance for doubtful accounts
-29,000,000 JPY
-29,000,000 JPY
Other
1,830,000,000 JPY
1,519,000,000 JPY
Non-current assets
Property, plant and equipment
Property, plant and equipment
28,777,000,000 JPY
25,834,000,000 JPY
Intangible assets
Intangible assets
5,119,000,000 JPY
5,393,000,000 JPY
Investments and other assets
Assets
178,942,000,000 JPY
176,045,000,000 JPY
Liabilities
Current liabilities
Short-term borrowings
10,100,000,000 JPY
10,100,000,000 JPY
Notes and accounts payable - trade
14,155,000,000 JPY
13,762,000,000 JPY
Income taxes payable
272,000,000 JPY
2,027,000,000 JPY
Current portion of long-term borrowings
10,200,000,000 JPY
200,000,000 JPY
Provisions
Provision for bonuses
1,117,000,000 JPY
2,182,000,000 JPY
Other
11,742,000,000 JPY
6,710,000,000 JPY
Current liabilities
47,588,000,000 JPY
34,983,000,000 JPY
Non-current liabilities
Long-term borrowings
485,000,000 JPY
10,636,000,000 JPY
Retirement benefit liability
3,550,000,000 JPY
3,721,000,000 JPY
Other
740,000,000 JPY
776,000,000 JPY
Non-current liabilities
4,777,000,000 JPY
15,600,000,000 JPY
Liabilities
52,365,000,000 JPY
50,584,000,000 JPY
Liabilities and net assets
Shareholders' equity
123,390,000,000 JPY
122,182,000,000 JPY
Share capital
700,000,000 JPY
700,000,000 JPY
Capital surplus
4,752,000,000 JPY
4,752,000,000 JPY
Retained earnings
135,287,000,000 JPY
134,396,000,000 JPY
Treasury shares
-17,350,000,000 JPY
-17,666,000,000 JPY
Valuation and translation adjustments
3,186,000,000 JPY
3,278,000,000 JPY
Valuation difference on available-for-sale securities
5,262,000,000 JPY
5,695,000,000 JPY
Foreign currency translation adjustment
386,000,000 JPY
340,000,000 JPY
Net assets
126,576,000,000 JPY
125,461,000,000 JPY
Liabilities and net assets
178,942,000,000 JPY
176,045,000,000 JPY
Net assets
Shareholders' equity
Valuation and translation adjustments
Remeasurements of defined benefit plans
-2,462,000,000 JPY
-2,756,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.